May 27, 2021
Biomarker synthesized by Th17 cells appears to differentiate myocarditis from MI
Differentiating acute myocarditis from myocardial infarction (MI) requires either an invasive biopsy or cardiac MRI technology that is not always available so the possibility that a microRNA biomarker in circulating T cells could be used to confirm myocarditis is appealing.
Identifying that novel miRNA was the goal of Rafael Blanco-Dominguez, MSc, of the Vascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares in Madrid, and a team of international researchers, who started by inducing autoimmune myocarditis or myocardial infarction in mice to identify the microRNA found in Th17 cells in plasma of mice with acute myocarditis either autoimmune or virus-induced.
EQS-News: Dynamics Group AG: ACM Biosciences und Dr Steve Pascolo, Universitätsspital Zürich, erhalten prestigeträchtiges Fördergeld der Innosuisse für die Zusammenarbeit und Entwicklung eines stabilen mRNA COVID-19-Impfstoffs
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Jede Stadt hat einzigartige Mikroben - Schweizer Bauer
schweizerbauer.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from schweizerbauer.ch Daily Mail and Mail on Sunday newspapers.
EQS-News: ACM Biosciences und Dr Steve Pascolo, Universitätsspital Zürich, | Newsticker
fuw.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fuw.ch Daily Mail and Mail on Sunday newspapers.